Growth Metrics

HeartSciences (HSCS) Shares Outstanding (Weighted Average) (2021 - 2026)

HeartSciences filings provide 6 years of Shares Outstanding (Weighted Average) readings, the most recent being $3.2 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 253.7% to $3.2 million in Q1 2026 year-over-year; TTM through Jan 2026 was $3.2 million, a 253.7% increase, with the full-year FY2025 number at $938257.0, up 166.16% from a year prior.
  • Shares Outstanding (Weighted Average) hit $3.2 million in Q1 2026 for HeartSciences, up from $2.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $8.2 million in Q1 2023 to a low of $79506.0 in Q2 2023.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $917445.0 (2024), compared with a mean of $2.2 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): plummeted 98.46% in 2023 and later skyrocketed 760.79% in 2024.
  • HeartSciences' Shares Outstanding (Weighted Average) stood at $6.9 million in 2022, then plummeted by 98.46% to $106582.0 in 2023, then skyrocketed by 760.79% to $917445.0 in 2024, then soared by 128.57% to $2.1 million in 2025, then skyrocketed by 50.8% to $3.2 million in 2026.
  • The last three reported values for Shares Outstanding (Weighted Average) were $3.2 million (Q1 2026), $2.1 million (Q4 2025), and $1.3 million (Q3 2025) per Business Quant data.